1. Pfizer (USA) and BioNTech (Germany) News: Pfizer and BioNTech have submitted a new application to the European Medicines Agency for a COVID-19 vaccine adapted to the 2025–2026 LP.8.1 strain. Pfizer and BioNTech Submit EMA Application for COVID-19 Vaccine Targeting LP.8.1 for 2025-2026 Season | Pfizer 2. Moderna (USA) News: Moderna’s pediatric COVID-19 vaccine received full approval in the U.S. for high-risk children. FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children 3. GlaxoSmithKline (UK) News: GSK expands its indications for its vaccine portfolio-, focusing on new RSV vaccines for adults. US FDA accepts application to review expanded use of GSK’s RSV vaccine, Arexvy, for adults 18-49 at increased risk | GSK US 4. Merck/MSD (USA) News: Merck advances its HPV vaccination programs and launches trials for next-generation vaccines. Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9 – Merck.com 5. Serum Institute of India...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
